Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and treatment of critically ill patients
Archeon has raised $9.0M in total funding. The most recent round was Series A. The last funding was announced in October 2026.
Archeon's investors include Bpifrance, Daphni, Newfund, Eiffel Investment Group, UI Investissement.
Archeon is headquartered in Besançon, France.
Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and treatment of critically ill patients
Archeon is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Archeon — Funding & Investors." VCBacked, October 6, 2026, https://www.vcbacked.co/company/archeon. Accessed November 14, 2026.
VCBacked. (2026). Archeon — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/archeon
{{cite web |title=Archeon — Funding & Investors |url=https://www.vcbacked.co/company/archeon |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Archeon? Request a listing update